tejo
23 Apr 2019
Another AMS Report in todays IC 12.4.19 SP looking very firm and remains an attractive investment
pete44
12 Apr 2019
Another AMS Report in todays IC 12.4.19 AMS still stands out Bull points : Strong 2018 numbers, Earnings forecast upgrades, Financial flexibility, Acquisition opportunities . Bear points: Regulatory changes, Brexit risk. …AMS’s own acquisition firepower has been bolstered by a new £80m revolving credit facility, as well as £76.4m-worth of net cash…AMS has also decided to change its divisional reporting, splitting itself into two: the higher-marginal surgical division and the lower growth, but still cash generative wound care segment. This could improve market perception…good consistent growth…Buy
pete44
22 Mar 2019
AMS Report in todays IC AMS expands into new markets… IC comment…AMS says it’s product portfolio and regulatory strength engenders" significant opportunities in our large and growing markets" -especially in anticipation of the EU’s medical device regulation. Products are already being withdrawn from the market, and it believes " stronger more capable players are in space" should benefit. But while the shares trade at a (not inexpensive ) 29 times forecast earnings, we prefer to observe from a neutral position
pete44
16 Mar 2019
Results - Dividend raised 20% Nice rise on Friday, hoping back to 350. Thought everyone had immigrated or no one likes this new system
Gamesinvestor1
13 Mar 2019
Results - Dividend raised 20% Looks like continued very good progress LONDON (Alliance News) - Surgical wound care firm Advanced Medical Solutions Group PLC hiked its 2018 dividend Wednesday after profit and revenue both grew amid “strong†financial and strategic progress. In 2018, pretax profit widened 12% to GBP28.4 million from GBP25.3 million the year prior. This was after revenue rose 5.9% to GBP102.6 million from GBP96.9 million the year before. “2018 was AMS’s seventeenth consecutive year of growth with strong financial and strategic progress across the group,†Chief Executive Officer Chris Meredith said. “Our solid revenue growth was driven by sales in our Branded division which included LiquiBand topical tissue adhesives further increasing market share a further 2%, and the growth of our Internal Adhesives and Biosurgical devices.†Advanced Medical proposed a 0.90 pence per share final dividend. For the full year, the dividend rose 20% to 1.32p from 1.10p the year before. Net cash advanced 22% to GBP76.4 million from GBP62.5 million the year before. “We have further reaffirmed our commitment to innovation through the acquisition of Sealantis which now opens up the large internal sealants market for the group,†Meredith added. “We are well positioned to take advantage of market opportunities across our product portfolio, and we continue to actively review M&A opportunities.†At the end of January, Advanced Medical bought alginate-based tissue adhesive technology firm Sealantis Ltd for USD25 million. Shares in Advanced Medical were flat at 305.50 pence on Wednesday. Games
share_123_maiden
10 Aug 2018
Aim's young medical companies Another bit of good news from this company today. [link]
pete44
09 Jul 2018
Aim's young medical companies GI Need your email address ( email me [email protected] )
pete44
09 Jul 2018
Aim's young medical companies GI Will email you the complete article. Struggling with this new site, not half as good as the previous
Gamesinvestor1
09 Jul 2018
Aim's young medical companies Pete any chance you could cut and paste the relevant parts? Games
pete44
07 Jul 2018
Aim's young medical companies A good 6 page article in this weeks IC on very good medical companies including AMS. A very good read
pete44
28 Apr 2018
To GI Thanks for your comment...totally agree with you. Onwards and upwards.
gamesinvestor
27 Apr 2018
Re: AMS No. 24 in top 100 AIM in Investors C... Pete, If AMS cracks just 2% of the US market for it's liquiband products it will be equivalent to double the market cap of AMS today -- you can almost forget the European market, which they won't because they will still grow the business there as well.I would bin the Investors Chronicle -- I've yet to see them get much right.Games
pete44
27 Apr 2018
AMS No. 24 in top 100 AIM in Investors Chronicle The US now represents the largest market and sales grew a whopping47% in 2017........Unfortunately trading in Europe is a little trickier.....they are remaining neutral until a broader picture improves. Recommend a HOLD
gamesinvestor
26 Apr 2018
Added to my holding at 308 ish to take this to 3.05% of my portfolio.Here's hoping Chris Meredith can crack open a lot more of that US market with liquiband.Games
BigBobby20
23 Apr 2018
Re: About turn? Hi Pete44:Yes, I am optimistic about the return to test 350p and then, with a fair wind, onwards to 400p at some point in the coming autumn. This is, of course, predictive reasoning, which leaves us some way short of a certainty. Admittedly, some will consider this to be a step too far in hope and ambition. However, most investors here will remember the giddying journey in overdrive from circa 195p at the end of Jan. 2017 to 315p by September of that year (better than 60% up). All we require from the SP at this level is a more modest improvement of around 27% in the course of the next six or seven months. That seems quite achievable to me and more likely than not. BB20
